Baisan Pharmaceutical (301096.SZ): The innovative drug BIOS-0623-Z4 tablets have been approved for clinical trials.

Financial APP News, Baisong Pharmaceutical (301096.SZ) announced that the company recently learned that its independently developed innovative drug BIOS-0623-Z4 tablets has obtained the Clinical Trial Approval Notice from the National Medical Products Administration (NMPA).